The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Exposure-response and PD-L1 expression analysis of second-line avelumab in patients with advanced NSCLC: Data from the JAVELIN Solid Tumor trial.
 
James L. Gulley
Consulting or Advisory Role - TRM Oncology
Research Funding - Astellas Medivation (Inst); Bavarian Nordic (Inst); Celgene (Inst); EMD Serono (Inst); Pfizer (Inst)
Travel, Accommodations, Expenses - Prime Oncology; TRM Oncology
 
David R. Spigel
Consulting or Advisory Role - AstraZeneca (Inst); Boehringer Ingelheim (Inst); Bristol-Myers Squibb (Inst); Celgene (Inst); Clovis Oncology (Inst); Genentech/Roche (Inst); Lilly (Inst); Novartis (Inst); Pfizer (Inst)
Research Funding - Amgen (Inst); AstraZeneca (Inst); Boehringer Ingelheim (Inst); Bristol-Myers Squibb (Inst); Celgene (Inst); Clovis Oncology (Inst); Daiichi Sankyo (Inst); Genentech/Roche (Inst); Lilly (Inst); Merck (Inst); Novartis (Inst); Oncogenex (Inst); OncoMed (Inst); Peregrine Pharmaceuticals (Inst); Pfizer (Inst); University of Texas Southwestern Medical Center - Simmons Cancer Center (Inst); Verastem (Inst)
 
Karen Kelly
Honoraria - Bristol-Myers Squibb; Merck; Roche
Consulting or Advisory Role - ARIAD; ARIAD; AstraZeneca; AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb; Clovis Oncology; G1 Therapeutics; Genentech/Roche; Lilly; Lilly; Synta
Research Funding - Abbvie (Inst); Celgene (Inst); EMD Serono (Inst); Five Prime Therapeutics (Inst); Genentech (Inst); Gilead Sciences (Inst); Lilly (Inst); Millennium (Inst); Novartis (Inst); Transgene (Inst)
Patents, Royalties, Other Intellectual Property - Author Royalties for UpToDate, an evidence based, peer reviewed information resource, available via the web, desktop, and PDA.
Travel, Accommodations, Expenses - ARIAD; AstraZeneca; Bristol-Myers Squibb; Genentech/Roche; Merck; Roche
 
Joseph Aisner
Honoraria - Ethicon
Consulting or Advisory Role - Bristol-Myers Squibb; EMD Serono
 
Vikram K. Chand
Employment - Boehringer Ingelheim; EMD Serono
Leadership - Boehringer Ingelheim; EMD Serono
Stock and Other Ownership Interests - Bristol-Myers Squibb
Research Funding - Boehringer Ingelheim; EMD Serono
Travel, Accommodations, Expenses - Boehringer Ingelheim; EMD Serono
Other Relationship - Boehringer Ingelheim; EMD Serono
 
Andre Koenig
Employment - EMD Serono; Merck KGaA
Stock and Other Ownership Interests - EMD Serono; Merck KGaA
Travel, Accommodations, Expenses - EMD Serono; Merck KGaA
 
Hugues Dolgos
Stock and Other Ownership Interests - Merck; Sanofi
Travel, Accommodations, Expenses - Merck
Other Relationship - Merck
 
Shaonan Wang
Employment - Merck
Patents, Royalties, Other Intellectual Property - Grunenthal
Travel, Accommodations, Expenses - Merck
 
Claire F. Verschraegen
Employment - University of Vermont Medical Group